Author:
Flux Glenn D.,Haq Masud,Chittenden Sarah J.,Buckley Susan,Hindorf Cecilia,Newbold Kate,Harmer Clive L.
Publisher
Springer Science and Business Media LLC
Subject
Radiology Nuclear Medicine and imaging,General Medicine,Radiology Nuclear Medicine and imaging,General Medicine
Reference30 articles.
1. Haq M, Harmer C. Non-surgical management of thyroid cancer. In: Mazzaferri EL, Harmer C, Mallick U, Kendall-Taylor P, editors. Practical management of thyroid cancer. London: Springer-Verlag; 2006. p. 171–91.
2. Pacini F, Schlumberger M, Dralle H, Elisei R, Smit JWA, Wiersinga W. European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium. Eur J Endocrinol. 2006;154(6):787–803.
3. Hackshaw A, Harmer C, Mallick U, Haq M, Franklyn JA. Review: I-131 activity for remnant ablation in patients with differentiated thyroid cancer: a systematic review. J Clin Endocrinol Metab. 2007;92(1):28–38.
4. Mallick U, Harmer C, Hackshaw A. The HiLo trial: a multicentre randomised trial of high- versus low-dose radioiodine, with or without recombinant human thyroid stimulating hormone, for remnant ablation after surgery for differentiated thyroid cancer. Clin Oncol. 2008;20(5):325–6.
5. Benua RS, Cicole NR, Sonenburg N, Rawson RW. The relation of radioiodine dosimetry to results and complications in the treatment of metastatic thyroid carcinoma. Am J Roentgenol Radium Ther Nucl Med. 1962;87:171–82.
Cited by
82 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献